Program Year 2019
General Payments624,738 providers 1,683 companies
Dataset totals — PY2019
$2,433,399,762.53
- Category: General Payments
- Program year: 2019
- Records: 10,508,629
- Providers: 624,738
- Reporting companies: 1,683
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- Dataset-level totals for the labeled program year, General Payments only. Research and Ownership/Investment are separate datasets and are never combined into these figures.
- Methodology & Data — sourcing, labeling, and limitations.
Coverage: program years 2018–2024 are loaded, General Payments only. This page reflects the CMS publication snapshot for PY2019.
Reported totals by company — PY2019 (20 shown)
Sorted by reported total — a dataset fact, not a ranking of conduct.
| Company | Reported | Records | Providers |
|---|---|---|---|
| Stryker Corporation | $142,994,731.60 | 121,079 | 23,272 |
| DePuy Synthes Products LLC | $135,225,074.64 | 2,874 | 410 |
| Zimmer Biomet Holdings, Inc. | $85,022,794.58 | 88,174 | 24,434 |
| BOSTON SCIENTIFIC CORPORATION | $81,543,305.65 | 165,870 | 43,213 |
| Medtronic USA, Inc. | $81,511,406.33 | 95,309 | 20,304 |
| Arthrex, Inc. | $78,258,434.80 | 43,274 | 3,900 |
| Allergan Inc. | $74,358,631.31 | 383,872 | 84,422 |
| ABBVIE INC. | $52,742,110.25 | 334,285 | 61,253 |
| INTUITIVE SURGICAL, INC. | $45,268,813.19 | 103,846 | 12,382 |
| Acerta Pharma LLC | $41,554,475.97 | 414,385 | 77,949 |
| Amgen Inc. | $40,199,477.23 | 391,637 | 77,790 |
| Medtronic Vascular, Inc. | $38,345,925.93 | 131,012 | 21,984 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $38,099,533.76 | 351,551 | 76,122 |
| Lilly USA, LLC | $36,797,789.10 | 293,343 | 51,423 |
| PFIZER INC. | $36,587,079.12 | 508,019 | 103,627 |
| Janssen Pharmaceuticals, Inc | $34,105,112.35 | 342,196 | 74,844 |
| Merck Sharp & Dohme Corporation | $33,985,819.80 | 266,071 | 80,918 |
| Smith & Nephew, Inc. | $29,610,927.17 | 73,904 | 19,605 |
| Abbott Laboratories | $28,227,264.46 | 155,704 | 31,873 |
| Novo Nordisk AS | $26,673,636.94 | 386,911 | 53,037 |
Reported totals by specialty — PY2019 (20 shown)
Sorted by reported total.
Other program years
Natures of payment
- Royalty or License
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
- Consulting Fee
- Food and Beverage
- Acquisitions
- Travel and Lodging
- Education
- Honoraria
- Current or prospective ownership or investment interest
- Grant
- Compensation for serving as faculty or as a speaker for a medical education program
- Gift
- Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program
- Debt forgiveness
- Long term medical supply or device loan
- Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program
- Charitable Contribution
- Entertainment